Article

Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain.

Neurogenomiks Laboratory, University of the Basque Country (UPV/EHU), Leioa, Spain.
Journal of neuroimmunology (Impact Factor: 2.79). 06/2010; 223(1-2):100-3. DOI: 10.1016/j.jneuroim.2010.03.020
Source: PubMed

ABSTRACT A recent meta-analysis of genome-wide association screens coupled to a replication exercise in a combined US/UK collection led to the identification of 4 single nucleotide polymorphisms (SNPs) in three gene loci, i.e. TNFRSF1A, CD6 and IRF8, as novel risk factors for multiple sclerosis with genome-wide level of significance. In the present study, using a combined all-Spain collection of 2515 MS patients and 2942 healthy controls, we demonstrate significant association of rs17824933 in CD6 (P(CMH)=0.004; OR=1.14; 95% CI 1.04-1.24) and of rs1860545 in TNFRSF1A (P(CMH)=0.001; OR=1.15; 95% CI 1.06-1.25) with MS, while the low-frequency coding non-synonymous SNP rs4149584 in TNFRSF1A displayed a trend for association (P(CMH)=0.062; OR=1.27; 95% CI 0.99-1.63). This data reinforce a generic role for CD6 and TNFRSF1A in susceptibility to MS, extending to populations of southern European ancestry.

0 Followers
 · 
113 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: ALCAM and CD6 may play an important role in the pathogenesis of multiple sclerosis (MS), since they are involved in the transmigration of leukocytes across blood-brain barrier. In this study, we confirmed our previous findings about association of ALCAM gene with risk, development and progression of MS. Additionally, we showed that in the case of CD6 gene (encoding receptor of ALCAM) not only polymorphisms but also mRNA expression level are associated with MS. Our analysis revealed that the risk of the disease for AA individuals in rs12360861 was almost 3.0-fold lower in comparison to GG individuals (OR=0.34; CI95%=0.12;0.81). Moreover, we observed lower expression of CD6 mRNA in patients than in healthy individuals (T22,74= 6.678; p=0.002).
    Journal of Neuroimmunology 08/2014; DOI:10.1016/j.jneuroim.2014.08.621 · 2.79 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Correlation between gadolinium-enhancing [Gd(+)] lesions on MRI and expression of CD6 molecule and a group of chemokine receptors on peripheral blood (PB) and cerebrospinal fluid (CSF) immune cells was measured in multiple sclerosis (MS) patients. Twenty remitting relapsing MS patients with (n = 10) and without (n = 10) Gd(+) lesions entered the study. mRNA and surface expression of CD6 and CCR1, CCR2, CCR3 and CCR5 was measured by immunostaining and flow cytometry. Expression of mRNA and surface staining for CD6 in PB T lymphocytes was increased in Gd(+) compared to Gd(-) patients (p < 0,01; p < 0,05, respectively). CD6 mRNA correlated with the number and size of Gd(+) lesions (r = 0,67, and r = 0,65 respectively). mRNA and surface expression for CCR1, CCR2, and CCR3 in PB cells was lower in Gd(+) compared to Gd(-) MS patients (p < 0,05, p < 0,05). The frequency of cells co-expressing CD6 with CCR1 and CCR5 was low in PB T lymphocytes and high in CSF (p < 0,05, p < 0,05). These results suggest that Gd(+) correlates with increased expression of CD6 and decresed expression of chemokine receptors on PB T lymphocytes. Co-expression of CD6 with CCR1 and CCR5 predisposes cells for transmigration into CSF.
    Journal of Neuroimmunology 08/2014; DOI:10.1016/j.jneuroim.2014.08.620 · 2.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Multiple sclerosis (MS) is a chronic neuro-inflammatory disease of complex etiology. The results of GWAS, a high-throughput method to discover genetic architectureof MS, require replication in independent ethnic groups. We performed a replication study of nine GWAS-identified SNPs in immune response in Russians. Associations of CLEC16A and IL2RA with MS were validated. Besides, we observed the associations of CLEC16A and IRF8 in women, and IL7RA and CD58 in men. With multi-locus association analysis two protective biallelic combinations: (TNFRSF1A*T+CLEC16A*A) and (TNFRSF1A*T+IRF8*A) were identified in women. Associations of CLEC16A*G/G and both biallelic combinations in women with MS survived the permutation test. Copyright © 2015 Elsevier B.V. All rights reserved.
    Journal of Neuroimmunology 03/2015; 282. DOI:10.1016/j.jneuroim.2015.03.015 · 2.79 Impact Factor

Bhairavi Swaminathan